Asuka Pharmaceutical will transfer 22,198 shares of treasury stock to the employee shareholding association, with a disposal price of \u00a52,259 per share, totaling approximately \u00a550.1 million. The system aims to enhance employee engagement and improve corporate value over the medium to long term, scheduled for implementation on November 2, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4886","jir_company_name":"Asuka Pharmaceutical Holdings Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4886-20260713-02.pdf","jir_short_summary":"Asuka Pharmaceutical will transfer 22,198 shares of treasury stock to the employee shareholding association, with a disposal price of \u00a52,259 per share, totaling approximately \u00a550.1 million. The system aims to enhance employee engagement and improve corporate value over the medium to long term, scheduled for implementation on November 2, 2026.","jir_summary":"### Summary of the Disposal\nAsuka Pharmaceutical plans to allocate 22,198 shares of treasury stock as transfer-restricted stock to the employee shareholding association. The disposal price is \u00a52,259 per share, with a total of approximately \u00a550.1 million, scheduled for November 2, 2026. The system aims to improve employee engagement and enhance corporate value over the medium to long term, applicable to up to 777 target employees.\n\n### Purpose and Background of the System\nThis system was introduced to support employees' wealth formation and to promote value sharing between employees and shareholders, aiming to enhance corporate value. The dilution scale of the disposed shares is approximately 0.08% of all issued shares, considered to have a limited market impact. The disposal will be carried out during the transfer restriction period, with conditions set for transfer restriction release based on continued employment, resignation, overseas transfer, etc., of employees.","jir_financial_highlights":"Number of shares disposed of: 22,198 shares (Unknown)\nDisposal price: \u00a52,259 per share (Unknown)\nTotal disposal amount: \u00a550,145,282 (Unknown)","jir_category":"","jir_hashtags":"#AsukaPharmaceutical, #ShareBuyback, #JapaneseStocks","jir_key_figures":"Number of shares disposed: 22,198 shares\nDisposal price: \u00a52,259 per share\nTotal disposal amount: \u00a550,145,282","jir_meta_title":"\u3010Asuka Pharmaceutical\u3011Share Buyback for Employee Shareholding Association | November 2, 2026","jir_meta_description":"Asuka Pharmaceutical will dispose of 22,198 shares of treasury stock, with a disposal price of \u00a52,259 per share and a total of approximately \u00a550.1 million. The system aims to improve employee engagement and corporate value.","jir_og_title":"\u3010Asuka Pharmaceutical\u3011Share Buyback for Employee Shareholding Association | November 2, 2026","jir_og_description":"Asuka Pharmaceutical will dispose of treasury stock to enhance employee engagement and improve corporate value over the medium to long term.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17164,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-79921","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n